Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Goodova-L Tablet

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Letrozole (2.5mg)

Overview Goodova-L Tablet

Post-menopausal women with breast cancer may find relief with Goodova-L Tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. For advanced breast cancer, it aids in metastasis prevention. Goodova-L Tablets may be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal efficacy. Dosage frequency varies based on the treatment goals, determined by your doctor to manage your symptoms effectively. Continuous use, as directed, is crucial. Common side effects include hot flushes, tiredness, excessive sweating, and elevated cholesterol. Report any concerning or persistent side effects to your physician; management strategies may be available. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you are currently using, as interactions may impact Goodova-L's effectiveness. Disclose pregnancy or breastfeeding status to your physician. Pre- and ongoing treatment blood tests to monitor vitamin D levels and bone density may be conducted.

Uses of Goodova-L Tablet

Managing breast cancer

Major Benefits of Goodova-L Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Goodova-L Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Goodova-L Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Goodova-L Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Goodova-L Tablets can be consumed with or without food, though consistent timing is recommended.

How Goodova-L Tablet works:

Goodova-L Tablets function as an aromatase inhibitor, reducing the body's estrogen production—a key female hormone. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Goodova-L Tablet consumption alongside alcohol poses no known adverse reactions.

PregnancyPregnancyUNSAFE

Employing Goodova-L tablets while pregnant poses a substantial risk. Pregnant women should consult their physician; research in animal and human studies indicates considerable harm to the fetus.

Breast feedingBreast feedingUNSAFE

Lactation and Goodova-L tablets are incompatible; evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Goodova-L Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Goodova-L Tablets are considered safe for individuals with kidney disease, and no dosage modification is typically advised. Nevertheless, data regarding its use in patients experiencing end-stage renal failure is scarce. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Goodova-L Tablets; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Goodova-L Tablet :

Should you forget a Goodova-L Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Goodova-L Tablet

LabelValue
Type of Compound Benzophenone-related compound
Addictive None.
Medication Classification Cancer medications

FAQs on Goodova-L Tablet

Goodova-L tablets function as an aromatase inhibitor, typically prescribed for postmenopausal women with breast cancer, including those whose menstruation has ceased due to surgery, chemotherapy, or natural menopause.
Goodova-L tablets function as an aromatase inhibitor, a class of anti-estrogen medication. This effect stems from its ability to suppress estrogen synthesis by inhibiting the aromatase enzyme, crucial for estrogen production. Estrogen fuels the growth of specific breast cancers, termed "estrogen-receptor-positive" cancers. Therefore, lowering estrogen levels can impede cancer progression.
For advanced breast cancer, or cancer that has metastasized, Goodova-L Tablet use should continue until tumor progression is observed. Following tamoxifen therapy or surgery, Goodova-L Tablet administration is indicated for five years, or until recurrence, whichever occurs earlier. Alternatively, a sequential regimen of two years of Goodova-L Tablet followed by three years of tamoxifen may be employed.
Concurrent use of irbesartan and Goodova-L tablets is permissible. Nevertheless, diligent blood pressure monitoring is advised, as Goodova-L tablets can elevate blood pressure. Seek medical attention if blood pressure management proves difficult.
The development of cataracts, while rare, is a potential side effect of Goodova-L Tablet. Therefore, prompt medical attention is advised should you notice visual disturbances such as blurred vision or eye discomfort.
Experiencing this symptom might indicate hot flashes, a frequent side effect of Goodova-L Tablet. This occurs because of reduced estrogen. The incidence of hot flashes typically lessens as your body adapts to Goodova-L Tablet. Nevertheless, for some individuals, these episodes may persist throughout treatment and subside only after a few months post-treatment. If the discomfort is significant, seek advice from your physician for appropriate management.
While uncommon, Goodova-L Tablet may cause serious adverse events in a small percentage of patients. These include stroke, angina pectoris, myocardial infarction, thromboembolic events, cataracts, osteoporosis, and severe dermatological reactions.
Taking Goodova-L Tablets can lead to bone loss (osteoporosis) resulting from reduced estrogen. Your physician might assess your bone density to track osteoporosis risk before, throughout, and following your treatment.
The Ministry of Health and Family Welfare designates Goodova-L Tablets solely for the treatment of infertility caused by a lack of ovulation.
Goodova-L Tablet
112
MRP 130
13% off